RSLBF (RaySearch Laboratories AB) Cyclically Adjusted FCF per Share: $0.82 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RSLBF RaySearch Laboratories AB RSLBF
90 GF Score
Price $18.85
GF Value $20.98
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is RaySearch Laboratories AB Cyclically Adjusted FCF per Share?

RaySearch Laboratories AB RSLBF -21.46% 90 Cyclically Adjusted FCF per Share is $0.82 as of Mar. 2026. GuruFocus rates RSLBF with a GF Score™ of 90/100 and a GF Value™ of $20.98 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

RaySearch Laboratories AB's adjusted free cash flow per share for the three months ended in Mar. 2026 was $0.155. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.82 for the trailing ten years ended in Mar. 2026.

During the past 12 months, RaySearch Laboratories AB's average Cyclically Adjusted FCF Growth Rate was 0.10% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 8.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 12.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of RaySearch Laboratories AB was 23.70% per year. The lowest was 8.10% per year. And the median was 17.60% per year.

As of today (2026-07-20), RaySearch Laboratories AB's current stock price is $18.85. RaySearch Laboratories AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $0.82. RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF of today is 22.99.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of RaySearch Laboratories AB was 109.03. The lowest was 7.97. And the median was 23.60.


RaySearch Laboratories AB  (OTCPK:RSLBF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=18.85/0.82
=22.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of RaySearch Laboratories AB was 109.03. The lowest was 7.97. And the median was 23.60.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


RaySearch Laboratories AB Cyclically Adjusted FCF per Share Related Terms


RaySearch Laboratories AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for RaySearch Laboratories AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RaySearch Laboratories AB Cyclically Adjusted FCF per Share Chart

RaySearch Laboratories AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.59 0.47 0.69 0.65 0.77

RaySearch Laboratories AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.72 0.79 0.77 0.82

RSLBF vs VEEV, BTSG, TEM: Cyclically Adjusted FCF per Share Comparison

For the Health Information Services subindustry, RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaySearch Laboratories AB Cyclically Adjusted Price-to-FCF vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's Cyclically Adjusted Price-to-FCF falls into.


RSLBF
90GF Score
RaySearch Laboratories AB RSLBF
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RaySearch Laboratories AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, RaySearch Laboratories AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.155/133.5600*133.5600
=0.155

Current CPI (Mar. 2026) = 133.5600.

RaySearch Laboratories AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.052 101.019 0.069
201609 0.035 101.138 0.046
201612 0.235 102.022 0.308
201703 0.129 102.022 0.169
201706 0.087 102.752 0.113
201709 0.130 103.279 0.168
201712 0.163 103.793 0.210
201803 0.198 103.962 0.254
201806 0.049 104.875 0.062
201809 -0.042 105.679 -0.053
201812 0.390 105.912 0.492
201903 0.158 105.886 0.199
201906 0.425 106.742 0.532
201909 0.155 107.214 0.193
201912 0.251 107.766 0.311
202003 0.196 106.563 0.246
202006 0.424 107.498 0.527
202009 0.259 107.635 0.321
202012 0.180 108.296 0.222
202103 0.356 108.360 0.439
202106 0.202 108.928 0.248
202109 0.160 110.338 0.194
202112 0.091 112.486 0.108
202203 0.382 114.825 0.444
202206 0.035 118.384 0.039
202209 -0.089 122.296 -0.097
202212 0.178 126.365 0.188
202303 0.283 127.042 0.298
202306 0.029 129.407 0.030
202309 0.212 130.224 0.217
202312 0.146 131.912 0.148
202403 0.298 132.205 0.301
202406 0.268 132.716 0.270
202409 0.064 132.304 0.065
202412 0.112 132.987 0.112
202503 0.244 132.825 0.245
202506 0.055 133.699 0.055
202509 -0.195 133.480 -0.195
202512 0.347 133.390 0.347
202603 0.155 133.560 0.155

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.82 mean?
RaySearch Laboratories AB (RSLBF) has a Cyclically Adjusted FCF per Share of $0.82 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on RaySearch Laboratories AB and its competitors.
Is RaySearch Laboratories AB's Cyclically Adjusted FCF per Share too high?
RaySearch Laboratories AB's current Cyclically Adjusted FCF per Share is $0.82. Overall, RaySearch Laboratories AB has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does RaySearch Laboratories AB's Cyclically Adjusted FCF per Share compare to VEEV and BTSG?
RaySearch Laboratories AB's Cyclically Adjusted FCF per Share of $0.82 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted FCF per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on RaySearch Laboratories AB and its competitors. RaySearch Laboratories AB's current Cyclically Adjusted FCF per Share is $0.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RaySearch Laboratories AB stock overvalued right now?
Based on GuruFocus' analysis, RaySearch Laboratories AB (RSLBF) is currently considered Modestly Undervalued. The stock's GF Value™ is $20.98, compared to a current price of $18.85 — trading 10.2% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $0.82. RaySearch Laboratories AB's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For RaySearch Laboratories AB (RSLBF), the current Cyclically Adjusted FCF per Share is $0.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RaySearch Laboratories AB (RSLBF) Overvalued in 2026?

Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be undervalued. The current stock price of $18.85 is trading 10.2% below its estimated GF Value™ of $20.98. GuruFocus considers RaySearch Laboratories AB to be Modestly Undervalued.

Key valuation signals for RSLBF:

  • Cyclically Adjusted FCF per Share: $0.82
  • GF Value™: $20.98 vs. price of $18.85 (10.2% below fair value)
  • GF Score™: 90/100 with 2 warning signs

No single metric tells the full story. See the RSLBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


RaySearch Laboratories AB Business Description

Address Eugeniavagen 18C, Stockholm, SWE, 113 68
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
90GF Score

Get the complete analysis for RSLBF

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.85
Price
$20.98
GF Value